Zerusa was acquired by Vascular Solutions Inc., a Nasdaq quoted company in 2011. Zerusa manufactures and distributes Guardian® haemostasis valves and, prior to acquisition, had been distributing the valves in the US under an exclusive distribution relationship with Vascular Solutions Inc. Guardian® haemostasis valves are designed to maintain haemostasis during interventional catheterization procedures through a novel sealing system which allows simple introduction and removal of interventional devices while providing the option to lock guidewires in place. The acquisition has been effectuated through the original Zerusa operation in Galway, and VSI plans to substantially increase employment in Ireland as a result. VSI, on announcing the acquisition, confirmed that its intention is to maintain and grow US market-share as well as furthering other international prospects.

Visit: www.vasc.com